High-dose antioxidants for central serous chorioretinopathy; The randomized, placebo-controlled study. Full Text
BMC Ophthalmology, 07/17/2012
Ratanasukon M et al. – The high–dose antioxidants for acute central serous chorioretinopathy did not show any benefits in visual acuity and central macular thickness. However, the drugs might decrease the chance for fluorescein leakage and additional treatments at the end of the 3rd month.